Marietta Investment Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,436
Closed -$233K 178
2022
Q2
$233K Sell
1,436
-660
-31% -$104K 0.07% 161
2022
Q1
$394K Sell
2,096
-406
-16% -$77.1K 0.09% 144
2021
Q4
$663K Sell
2,502
-4,881
-66% -$1.31M 0.14% 113
2021
Q3
$2.13M Buy
+7,383
New +$1.89M 0.49% 53

Other funds holding RGEN

Marietta Investment Partners's RGEN Position: Q3 2022 in Review

Marietta Investment Partners sold out of Repligen (RGEN) in Q3 2022, closing a stake of 1,436 shares — an estimated $233K sold.

Marietta Investment Partners first reported a position in RGEN in Q3 2021 and held it in 4 quarters. The position peaked at $2.13M in Q3 2021. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.

  • Marietta Investment Partners reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
  • Marietta Investment Partners sold 1,436 Repligen shares in Q3 2022, an estimated $233K.
  • Marietta Investment Partners first reported a position in Repligen in Q3 2021 and held it in 4 quarters.
  • Marietta Investment Partners's Repligen position peaked at $2.13M in Q3 2021.
  • 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.

Based on Marietta Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.